MFDS — authorised 15 August 1994
- Marketing authorisation holder: MYLAN
- Status: likely_approved
🇰🇷 Cystagon in South Korea
MFDS authorised Cystagon on 15 August 1994
Marketing authorisation
Cystagon in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in South Korea
Frequently asked questions
Is Cystagon approved in South Korea?
Yes. MFDS authorised it on 15 August 1994.
Who is the marketing authorisation holder for Cystagon in South Korea?
MYLAN holds the South Korean marketing authorisation.